ATE243703T1 - Antibiotische azalid-zusammensetzungen - Google Patents

Antibiotische azalid-zusammensetzungen

Info

Publication number
ATE243703T1
ATE243703T1 AT00979850T AT00979850T ATE243703T1 AT E243703 T1 ATE243703 T1 AT E243703T1 AT 00979850 T AT00979850 T AT 00979850T AT 00979850 T AT00979850 T AT 00979850T AT E243703 T1 ATE243703 T1 AT E243703T1
Authority
AT
Austria
Prior art keywords
antibiotic
azalide
compositions
azalide compositions
antibiotic azalide
Prior art date
Application number
AT00979850T
Other languages
English (en)
Inventor
Wayne Alan Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22652702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE243703(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE243703T1 publication Critical patent/ATE243703T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00979850T 2000-01-27 2000-11-30 Antibiotische azalid-zusammensetzungen ATE243703T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17848100P 2000-01-27 2000-01-27
PCT/IB2000/001824 WO2001055158A1 (en) 2000-01-27 2000-11-30 Azalide antibiotic compositions

Publications (1)

Publication Number Publication Date
ATE243703T1 true ATE243703T1 (de) 2003-07-15

Family

ID=22652702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00979850T ATE243703T1 (de) 2000-01-27 2000-11-30 Antibiotische azalid-zusammensetzungen

Country Status (21)

Country Link
US (2) US6514945B1 (de)
EP (1) EP1250343B1 (de)
JP (2) JP3893059B2 (de)
AR (2) AR030045A1 (de)
AT (1) ATE243703T1 (de)
AU (1) AU779748C (de)
BR (2) BRPI0017013B1 (de)
CA (1) CA2398485C (de)
CO (1) CO5251404A1 (de)
DE (1) DE60003586T2 (de)
DK (1) DK1250343T3 (de)
ES (1) ES2199884T3 (de)
MX (1) MXPA02007305A (de)
NZ (1) NZ518665A (de)
PA (1) PA8509801A1 (de)
PE (1) PE20011050A1 (de)
PT (1) PT1250343E (de)
TN (1) TNSN01017A1 (de)
TW (2) TWI331527B (de)
WO (1) WO2001055158A1 (de)
ZA (1) ZA200205958B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
AU2005286723A1 (en) 2004-09-23 2006-03-30 Schering-Plough Pty. Limited Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
DE602005017419D1 (de) * 2004-11-19 2009-12-10 Schering Plough Ltd Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitril-derivaten
CA2609574A1 (en) * 2005-06-09 2006-12-21 Schering-Plough Ltd. Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
US20080044455A1 (en) * 2006-08-21 2008-02-21 Chaim Welczer Tonsillitus Treatment
CN101605756A (zh) * 2006-12-13 2009-12-16 先灵-普劳有限公司 氟苯尼考及其类似物的水溶性前药
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2549731T3 (es) 2007-06-27 2015-11-02 E. I. Du Pont De Nemours And Company Método para el control de plagas en animales
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
CN102131772B (zh) * 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
UA107804C2 (xx) 2009-08-05 2015-02-25 Du Pont Суміші мезоіонних пестицидів
AU2010279574A1 (en) 2009-08-05 2012-02-09 E. I. Du Pont De Nemours And Company Mesoionic pesticides
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
MX2012001646A (es) 2009-08-05 2012-03-21 Du Pont Pesticidas mesoionicos.
RS54677B1 (sr) 2010-05-27 2016-08-31 E. I. Du Pont De Nemours And Company Kristalni oblici 4-[5-[3-hloro-5-(trifluorometil)fenil]-4,5 -dihidro-5-(trifluorometil)-3-izoksazolil]-n-[2-okso-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenkarboksamida
US20130102551A1 (en) 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
US9212201B2 (en) * 2010-07-23 2015-12-15 Acea Biotech, Inc. Antifungal and antiparasitic polyene macrolides
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
CN103619818A (zh) 2011-06-20 2014-03-05 纳幕尔杜邦公司 用于治疗蠕虫感染的杂环化合物
EP2736915A1 (de) 2011-07-27 2014-06-04 Farma GRS, d.o.o. Neue kristalline formen von tulathromycin
BR112014007819B1 (pt) 2011-11-11 2021-03-02 Exxonmobil Upstream Research Company método para produzir hidrocarbonetos
BR112014007821B1 (pt) 2011-11-11 2021-12-07 Exxonmobil Upstream Research Company Método para determinar a localização, tamanho, e composição fluida de um acúmulo de hidrocarboneto abaixo da superfície
TW201326128A (zh) 2011-11-28 2013-07-01 Du Pont 磺醯胺驅蟲劑
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
RU2634793C1 (ru) 2014-03-07 2017-11-03 Эксонмобил Апстрим Рисерч Компани Способ разведки и система для обнаружения углеводородов по водяному столбу
CN104119413B (zh) * 2014-07-29 2016-08-24 华中农业大学 一种土拉霉素残留标示物的合成方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (de) 2015-03-25 2018-11-21 President and Fellows of Harvard College Makrolide mit modifizierten desosaminzuckern und verwendungen davon
WO2017124222A1 (zh) * 2016-01-18 2017-07-27 浙江海正药业股份有限公司 一种泰拉霉素的制备方法及其中间体
MX2021005421A (es) * 2018-11-19 2021-09-21 Zikani Therapeutics Inc Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.
TWI830987B (zh) 2020-03-12 2024-02-01 美商碩騰服務公司 免疫調節脲氮雜內酯
KR102589130B1 (ko) * 2021-03-24 2023-10-13 삼진제약주식회사 N-옥소 피리딘 화합물 발생을 억제하는 안질환 예방 또는 치료용 점안 조성물
MX2024002892A (es) 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.
EP4289268A1 (de) * 2022-06-07 2023-12-13 The Procter & Gamble Company Antimikrobielle zusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6128174A (en) 1997-08-29 2000-10-03 Stereotaxis, Inc. Method and apparatus for rapidly changing a magnetic field produced by electromagnets
ES2281136T3 (es) * 1997-09-10 2007-09-16 Merial Ltd. Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
DE60038610T2 (de) * 1999-05-18 2009-06-25 Pfizer Products Inc., Groton Neue kristalline formen eines makrolidantibiotikums

Also Published As

Publication number Publication date
PT1250343E (pt) 2003-11-28
US6514945B1 (en) 2003-02-04
DE60003586D1 (de) 2003-07-31
US20030013860A1 (en) 2003-01-16
CA2398485A1 (en) 2001-08-02
JP3893059B2 (ja) 2007-03-14
DE60003586T2 (de) 2004-01-08
TWI318880B (en) 2010-01-01
PA8509801A1 (es) 2002-02-21
MXPA02007305A (es) 2002-11-29
TNSN01017A1 (fr) 2005-11-10
BR0017013A2 (pt) 2010-07-13
WO2001055158A1 (en) 2001-08-02
DK1250343T3 (da) 2003-09-22
EP1250343A1 (de) 2002-10-23
AR030045A1 (es) 2003-08-13
AR039387A2 (es) 2005-02-16
NZ518665A (en) 2005-02-25
BRPI0017013B1 (pt) 2015-07-14
AU779748C (en) 2005-12-08
AU1722801A (en) 2001-08-07
BR0017013A (pt) 2002-10-22
JP2006282676A (ja) 2006-10-19
CA2398485C (en) 2008-01-29
ES2199884T3 (es) 2004-03-01
EP1250343B1 (de) 2003-06-25
CO5251404A1 (es) 2003-02-28
TW201006476A (en) 2010-02-16
BRPI0017013B8 (pt) 2022-11-16
PE20011050A1 (es) 2001-10-19
JP2004500384A (ja) 2004-01-08
US20030073825A1 (en) 2003-04-17
TWI331527B (en) 2010-10-11
ZA200205958B (en) 2003-09-29
US6667393B2 (en) 2003-12-23
AU779748B2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
DE60003586D1 (de) Antibiotische azalid-zusammensetzungen
ATE345350T1 (de) Makrolidantibiotika
ATE303787T1 (de) Schergelzusammensetzungen
DE60139185D1 (de) Vernetzbare perfluoroelastomarzusammensetzung
CY20162200002T2 (el) Αντιιικοι παραγοντες
IS2932B (is) Fúlvestrant samsetning
EP1267765A4 (de) Antibiotische und pilzbekämpfende mittel
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20001749A0 (fi) Farmaseuttisia koostumuksia
DE60131547D1 (de) Abführende zusammensetzungen
DK1147121T3 (da) Ketolidantibiotika
ITMI20010748A0 (it) Composizioni farmaceutiche
AR023440A1 (es) Composiciones antitranspirantes
ATE246449T1 (de) Antimikrobielle zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
DE60133154D1 (de) Antistatische Zusammensetzung
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60102050D1 (de) Glaszusammensetzung
NO20026123L (no) Farmasöytiske sammensetninger
NO20014362D0 (no) Erytromycinderivater
NO20031095L (no) Farmasoytiske sammensetninger
DE60116858D1 (de) Zusammensetzung
DE60139712D1 (de) Ionophore antibiotische formulierungen
AU2002317415A1 (en) Azalide antibiotic compositions
DE60107312D1 (de) Feste Zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250343

Country of ref document: EP